NEW YORK (GenomeWeb News) – California health officials have cleared Transgenomic to offer its molecular lab services in the state by certifying its lab, the company said today.
The company said it expects to start marketing a number of its services to California doctors right away, including tests for mitochondrial disorders, oncology, hematology, molecular pathology, and inherited diseases.
The company said its lab is CLIA certified, is compliant with Good Laboratory Practices, and is accredited by the College of American Pathologists.
Company CEO Craig Tuttle said in a statement that Transgenomic underwent a "rigorous certification process" to obtain the state license. "The state of California represents the largest market opportunity in the United States" for the company's molecular lab testing services, he added.